Dimitri–Sturge–Weber syndrome

From WikiMD's Medical Encyclopedia

Dimitri–Sturge–Weber syndrome (DSWS), also known as Sturge-Weber syndrome or encephalotrigeminal angiomatosis, is a rare congenital neurological disorder and skin disorder. It is characterized by a port-wine stain birthmark on the face, neurological abnormalities, and vascular eye abnormalities. DSWS is associated with a somatic mutation in the GNAQ gene, which occurs sporadically and is not inherited. The syndrome affects the development of certain blood vessels, causing abnormalities in the brain, skin, and eyes.

Symptoms and Signs[edit]

The most visible sign of Dimitri–Sturge–Weber syndrome is a facial port-wine stain, typically affecting one side of the face. The extent and location of the stain can vary. Additional symptoms include:

Causes[edit]

DSWS is caused by a somatic mutation in the GNAQ gene, which is not inherited but occurs randomly in a cell during early development. The GNAQ gene regulates blood vessel formation, and its mutation leads to the abnormal development of blood vessels in the brain, skin, and eyes associated with the syndrome.

Diagnosis[edit]

Diagnosis is based on clinical presentation, including:

Treatment[edit]

There is no cure for Dimitri–Sturge–Weber syndrome. Treatment focuses on managing symptoms and preventing complications, including:

  • Anticonvulsant medications: To control seizures.
  • Laser therapy: To reduce the appearance of the port-wine stain.
  • Regular eye examinations: To detect and treat glaucoma early.
  • Supportive therapies:
  • Physical therapy and occupational therapy to address developmental delays.
  • Educational support for intellectual disabilities.

Prognosis[edit]

The prognosis for individuals with DSWS varies widely depending on the severity of symptoms. Early and proactive management of seizures and glaucoma can significantly improve quality of life and outcomes.

See Also[edit]








NIH genetic and rare disease info[edit]

Dimitri–Sturge–Weber syndrome is a rare disease.


Stub icon
   This article is a  stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.